Syndromic Multiplex Diagnostic Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Syndromic Multiplex Diagnostic market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.
Syndromic Multiplex Diagnostic Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Syndromic Multiplex Diagnostic market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.
Syndromic multiplex testing utilizes the advanced technology of multiplex PCR which provides accurate and fast diagnostic results with the help of the multiple panels used in syndromic multiplex diagnostic to provide diagnostic results within an hour. The new generations of syndromic multiplex can rapidly identify the common type of pathogens in the respiratory specimens, blood and cerebrospinal. The use of multiplex panels is associated with quicker turnaround time, reduction of other unnecessary laboratory tests, faster diagnosis and targeted treatment.
Data Bridge Market Research analyses that the global Syndromic Multiplex Diagnostic Market will grow at a CAGR of 8.7% during the forecast period of 2022 to 2029.
Download PDF Sample Report (Including Graphs, Charts and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-syndromic-multiplex-diagnostic-market
Syndromic multiplex testing is used to diagnose many pathogens simultaneously. In the syndromic multiplex diagnostic, various types of reagents & consumables and instruments & accessories are used, which helps maintain accuracy and provide fast diagnosis results. These multiplex tests are rapidly diagnosed with certain infections, allowing clinical management decisions to be made promptly. The tests based on multiplex technology are known as test panels. The panels used in syndromic testing are designed to diagnose multiple diseases associated with the same or similar syndrome type. These panels help evaluate the cause of the disease at the point of care. Gastrointestinal panels and respiratory panels are the types of syndromic panels.
Syndromic multiplex diagnostic is a type of advanced diagnostic test utilised to detect infectious diseases such as respiratory infection, infective gastroenteritis, sexually transmitted infections, sepsis, and meningitis, among other types of infectious diseases. The syndromic multiplex diagnostic also helps the clinicians or hospitals to detect the symptoms and signs of the various types of diseases. This lets the health care providers provide the right treatment for the patients and offer more precise outcomes and care that can be performed more quickly.
Syndromic Multiplex Diagnostic Market Dynamics
Drivers
Rise in prevalence of infectious diseases
The rising incidence of infectious bacterial and viral diseases impacts the market’s demand because, in the syndromic testing, multiplex real-time PCR technique and the syndromic approach are used for molecular diagnostics of infectious diseases.
Rise in adoption of molecular diagnostic techniques
Molecular diagnostics also help address the need for tests that monitor the therapeutic efficacy of pharmaceuticals. In this way, diagnostic laboratories or other end-users provide the highest levels of reliability and the greatest speed.
Opportunities
Strategic Initiatives taken by market players
In March 2021, F. Hoffman-La Roche Ltd acquired GenMark Diagnostics, a leading multiplex molecular diagnostics provider. This acquisition has helped the company to broaden Roche’s molecular diagnostic portfolio. These strategic initiatives taken by the market players, including focused segment product launches, are helping them expand their global reach and enhance their product portfolio and acting as an opportunity for the market’s growth.
Rising Diagnostic Healthcare Expenditure
The growing healthcare expenditure is expected to increase the availability of services and affordability for the population to opt for better and more precise diagnostic services to manage their diseases. The increase in healthcare expenditure ensures better availability of diagnostic services. Hence, huge health care expenditure is a favourable factor and is acting as an opportunity for the growth of the syndromic multiplex diagnostic market.
Restraint/Challenge
High Cost of Diagnostic Products
The multiplex syndromic testing applications utilize the real-time Polymerase chain reaction (PCR), which delivers the results with amplification curves and correct values. The instruments used in the syndromic multiplex diagnostic require high maintenance costs. Hence, the high cost of instruments is a challenge for the market.
Some of the major players operating in the global syndromic multiplex diagnostic market are BioFire Diagnostics (A Subsidiary of bioMérieux SA), Seegene Inc., Luminex Corporation. A DiaSorin Company, F. Hoffmann-La Roche Ltd, BD, Bio-Rad Laboratories, Inc., Cepheid (A subsidiary of Danaher), QIAGEN, Abbott, Hologic, Inc., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Akonni Biosystems, Inc., Biocartis, QuantuMDx Group Ltd., Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH), Applied BioCode, Inc., Prominex Inc., Nanōmix, Inc., Curetis (A subsidiary of OpGen, Inc.), and MiRXES Pte Ltd. among others.
View Detailed Table of Content @ https://www.databridgemarketresearch.com/reports/global-syndromic-multiplex-diagnostic-market
Recent Developments
In March 2021, BioFire Diagnostics (A Subsidiary of biomérieux SA) received the market authorization for BioFire respiratory panel 2.1, a diagnostic test for detecting and identifying multiple respiratory viral and bacterial infections nucleic acids in nasopharyngeal swabs. This has helped the company to commercialize its product
In March 2021, F. Hoffmann-La Roche Ltd entered into a definitive merger agreement for Roche to fully acquire GenMark Diagnostics. This has helped the company to increase its portfolio
Syndromic Multiplex Diagnostic Market Scope
The syndromic multiplex diagnostic market is categorized into five notable segments based on product and services, infection type, disease, panels type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Reagents & Consumables
- Instruments, Software & Accessories
- Services
- Based on products and services, the global syndromic multiplex diagnostic market is segmented into reagents & consumables, instruments, software & accessories and services.
Infection Type
- Viral
- Bacterial
- Parasites
- Fungal
- Based on infection type, the global syndromic multiplex diagnostic market is segmented into viral, bacterial, parasites and fungal
Disease
- Respiratory Infection
- Gastroneteritis
- Sexually Transmitted Infections
- Sepsis
- Meningitis
- Others
- Based on disease, the global syndromic multiplex diagnostic market is segmented into respiratory infections, gastroenteritis, sexually transmitted infections, sepsis meningitis and others
Panels Type
- Respiratory Panel
- GI-Enteric Panel
- Sexually Transmitted Disease Panel
- Blood-Sepsis Panel
- Meningitis Panel
- Others
- Based on panels type, the global syndromic multiplex diagnostic market is segmented into respiratory panel, GI-enteric panel, sexually transmitted disease panel, blood-sepsis panel, meningitis panel and others
End User
- Hospitals
- Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Others
Browse the complete table of contents at https://www.databridgemarketresearch.com/toc/?dbmr=global-syndromic-multiplex-diagnostic-market
Related Reports:
Europe Syndromic Multiplex Diagnostic Market Size, Shares, Trends and Industry Growth Outlook: https://www.databridgemarketresearch.com/reports/europe-syndromic-multiplex-diagnostic-market
Asia-Pacific Syndromic Multiplex Diagnostic Market Size, Shares, Trends and Industry Growth Outlook: https://www.databridgemarketresearch.com/reports/asia-pacific-syndromic-multiplex-diagnostic-market
North America Syndromic Multiplex Diagnostic Market Size, Shares, Trends and Industry Growth Outlook: https://www.databridgemarketresearch.com/reports/north-america-syndromic-multiplex-diagnostic-market
Middle East and Africa Syndromic Multiplex Diagnostic Market Size, Shares, Trends and Industry Growth Outlook: https://www.databridgemarketresearch.com/reports/middle-east-and-africa-syndromic-multiplex-diagnostic-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475